Mitomycin C functions as an alkylating agent, which means it forms cross-links with DNA, disrupting its replication and transcription processes. This leads to the induction of apoptosis or cell death in rapidly dividing cancer cells. It is particularly effective in hypoxic tumor environments where other treatments may fail.
